TLR9 and steatosis: Although the biological significance of HBV-induced TLR9 impairment remains unclear, recent data suggest that TLR9 stimulation may induce liver damage (inflammation, fibrosis, steatosis), involving non-parenchymal liver components (stellate, Kupffer and sinusoidal endothelial cells) [40].